252 related articles for article (PubMed ID: 36960729)
1. Genetic Identification of Homozygous Familial Hypercholesterolemia by Long-Read Sequencing Among Patients With Clinically Diagnosed Heterozygous Familial Hypercholesterolemia.
Chaudhry A; Trinder M; Vesely K; Cermakova L; Jackson L; Wang J; Hegele RA; Brunham LR
Circ Genom Precis Med; 2023 Apr; 16(2):e003887. PubMed ID: 36960729
[TBL] [Abstract][Full Text] [Related]
2. Homozygous Familial Hypercholesterolemia in Spain: Prevalence and Phenotype-Genotype Relationship.
Sánchez-Hernández RM; Civeira F; Stef M; Perez-Calahorra S; Almagro F; Plana N; Novoa FJ; Sáenz-Aranzubía P; Mosquera D; Soler C; Fuentes FJ; Brito-Casillas Y; Real JT; Blanco-Vaca F; Ascaso JF; Pocovi M
Circ Cardiovasc Genet; 2016 Dec; 9(6):504-510. PubMed ID: 27784735
[TBL] [Abstract][Full Text] [Related]
3. How Genetic Variants in Children with Familial Hypercholesterolemia Not Only Guide Detection, but Also Treatment.
van den Bosch SE; Corpeleijn WE; Hutten BA; Wiegman A
Genes (Basel); 2023 Mar; 14(3):. PubMed ID: 36980941
[TBL] [Abstract][Full Text] [Related]
4. Phenotypical, Clinical, and Molecular Aspects of Adults and Children With Homozygous Familial Hypercholesterolemia in Iberoamerica.
Alves AC; Alonso R; Diaz-Diaz JL; Medeiros AM; Jannes CE; Merchan A; Vasques-Cardenas NA; Cuevas A; Chacra AP; Krieger JE; Arroyo R; Arrieta F; Schreier L; Corral P; Bañares VG; Araujo MB; Bustos P; Asenjo S; Stoll M; Dell'Oca N; Reyes M; Ressia A; Campo R; Magaña-Torres MT; Metha R; Aguilar-Salinas CA; Ceballos-Macias JJ; Morales ÁJR; Mata P; Bourbon M; Santos RD
Arterioscler Thromb Vasc Biol; 2020 Oct; 40(10):2508-2515. PubMed ID: 32757650
[TBL] [Abstract][Full Text] [Related]
5. Real-World Effectiveness of PCSK9 Inhibitors in Reducing LDL-C in Patients With Familial Hypercholesterolemia in Italy: A Retrospective Cohort Study Based on the AIFA Monitoring Registries.
Arca M; Celant S; Olimpieri PP; Colatrella A; Tomassini L; D'Erasmo L; Averna M; Zambon A; Catapano AL; Russo P
J Am Heart Assoc; 2023 Nov; 12(21):e026550. PubMed ID: 37850449
[TBL] [Abstract][Full Text] [Related]
6. Homozygous familial hypercholesterolemia in Italy: Clinical and molecular features.
Bertolini S; Calandra S; Arca M; Averna M; Catapano AL; Tarugi P;
Atherosclerosis; 2020 Nov; 312():72-78. PubMed ID: 32977124
[TBL] [Abstract][Full Text] [Related]
7. Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study.
Pirillo A; Garlaschelli K; Arca M; Averna M; Bertolini S; Calandra S; Tarugi P; Catapano AL;
Atheroscler Suppl; 2017 Oct; 29():17-24. PubMed ID: 28965616
[TBL] [Abstract][Full Text] [Related]
8. Impact of LDLR and PCSK9 pathogenic variants in Japanese heterozygous familial hypercholesterolemia patients.
Hori M; Ohta N; Takahashi A; Masuda H; Isoda R; Yamamoto S; Son C; Ogura M; Hosoda K; Miyamoto Y; Harada-Shiba M
Atherosclerosis; 2019 Oct; 289():101-108. PubMed ID: 31491741
[TBL] [Abstract][Full Text] [Related]
9. Genotype-phenotype correlation in a large cohort of pediatric patients with heterozygous and homozygous familial hypercholesterolemia.
Reijman MD; Defesche JC; Wiegman A
Curr Opin Lipidol; 2023 Dec; 34(6):287-295. PubMed ID: 36752612
[TBL] [Abstract][Full Text] [Related]
10. [Identifying possible homozygous familial hypercholesterolemia patients: an Italian experts' opinion].
Bilato C; Zambon A; Pisciotta L; Citroni N; Carubbi F; Zambon S; Zenti MG; Vinci P; Biolo G; Bonomo K; Egalini F; Passaro A; Nascimbeni F; Negri E; D'Addato S; Averna M; Arca M; Oliva F; Colivicchi F; Catapano A
G Ital Cardiol (Rome); 2023 Jan; 24(1):5-10. PubMed ID: 36573504
[TBL] [Abstract][Full Text] [Related]
11. Homozygous familial hypercholesterolaemia: update on management.
France M
Paediatr Int Child Health; 2016 Nov; 36(4):243-247. PubMed ID: 27967828
[TBL] [Abstract][Full Text] [Related]
12. Homozygous Familial Hypercholesterolemia Patients With Identical Mutations Variably Express the LDLR (Low-Density Lipoprotein Receptor): Implications for the Efficacy of Evolocumab.
Thedrez A; Blom DJ; Ramin-Mangata S; Blanchard V; Croyal M; Chemello K; Nativel B; Pichelin M; Cariou B; Bourane S; Tang L; Farnier M; Raal FJ; Lambert G
Arterioscler Thromb Vasc Biol; 2018 Mar; 38(3):592-598. PubMed ID: 29284604
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of Inclisiran in Patients Having Familial Hypercholesterolemia: Heterozygous Compared to Homozygous Trait, a Systematic Review and Meta-analysis.
Rai R; Devi P; Kumar K; Naeem K; Kumar H; Kumari K; Kumar A; Kumar A; Muhammad A; Khan MS; Qadir G; Ali S; Maheshwari M; Jawwad M
Crit Pathw Cardiol; 2024 Jun; 23(2):73-80. PubMed ID: 38446086
[TBL] [Abstract][Full Text] [Related]
14. A Low-Frequency APOB p.(Pro955Ser) Variant Contributes to the Severity of/Variability in Familial Hypercholesterolemia.
Hori M; Takahashi A; Hosoda K; Ogura M; Harada-Shiba M
J Clin Endocrinol Metab; 2023 Jan; 108(2):422-432. PubMed ID: 36190978
[TBL] [Abstract][Full Text] [Related]
15. Metabolic systems approaches update molecular insights of clinical phenotypes and cardiovascular risk in patients with homozygous familial hypercholesterolemia.
Du Z; Li F; Jiang L; Li L; Du Y; Yu H; Luo Y; Wang Y; Sun H; Hu C; Li J; Yang Y; Jiao X; Wang L; Qin Y
BMC Med; 2023 Jul; 21(1):275. PubMed ID: 37501168
[TBL] [Abstract][Full Text] [Related]
16. Elevated PCSK9 levels in untreated patients with heterozygous or homozygous familial hypercholesterolemia and the response to high-dose statin therapy.
Raal F; Panz V; Immelman A; Pilcher G
J Am Heart Assoc; 2013 Apr; 2(2):e000028. PubMed ID: 23537802
[TBL] [Abstract][Full Text] [Related]
17. Next-generation sequencing to confirm clinical familial hypercholesterolemia.
Reeskamp LF; Tromp TR; Defesche JC; Grefhorst A; Stroes ESG; Hovingh GK; Zuurbier L
Eur J Prev Cardiol; 2021 Jul; 28(8):875-883. PubMed ID: 34298557
[TBL] [Abstract][Full Text] [Related]
18. Elevated plasma PCSK9 level is equally detrimental for patients with nonfamilial hypercholesterolemia and heterozygous familial hypercholesterolemia, irrespective of low-density lipoprotein receptor defects.
Lambert G; Petrides F; Chatelais M; Blom DJ; Choque B; Tabet F; Wong G; Rye KA; Hooper AJ; Burnett JR; Barter PJ; Marais AD
J Am Coll Cardiol; 2014 Jun; 63(22):2365-73. PubMed ID: 24632287
[TBL] [Abstract][Full Text] [Related]
19. Plasma lipoprotein(a) levels in patients with homozygous autosomal dominant hypercholesterolemia.
Sjouke B; Yahya R; Tanck MWT; Defesche JC; de Graaf J; Wiegman A; Kastelein JJP; Mulder MT; Hovingh GK; Roeters van Lennep JE
J Clin Lipidol; 2017; 11(2):507-514. PubMed ID: 28502508
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
